However, yet another recent study reported that the publications regarding serum GPC3 for HCC diagnostics could be flawed due to different patient selection, sample size, heterogeneous experimental technique, and serum quality control [42]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.